Ballentine Partners LLC lessened its stake in shares of Bristol-Myers Squibb ( NYSE:BMY – Free Report ) by 11.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,872 shares of the biopharmaceutical company's stock after selling 4,283 shares during the quarter. Ballentine Partners LLC's holdings in Bristol-Myers Squibb were worth $2,209,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company.

https://www.dailypolitical.com/2023/07/14/bristol-myers-squibb-nysebmy-shares-sold-by-ballentine-partners-llc.html

#dailypolitical